The Perrigo Company (Nasdaq: PRGO) has entered into a purchase agreement to acquire nine generic prescription dermatological products ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE